Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pollak

Showing results (41-50 of 236) with videos related to

Pageof 24
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levelsCaroline Diorio, Jacques Brisson, Sylvie Bérubé, et al.
Aging|May 11, 2013
Metformin, aging and cancerOlga Moiseeva, Xavier Deschênes-Simard, Michael Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Vitamin D pathway polymorphisms in relation to mammographic breast densityCaroline Diorio, Marc Sinotte, Jacques Brisson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2016
Exercise and Prostate Cancer: Evidence and Proposed Mechanisms for Disease ModificationBrian D Hayes, Lauren Brady, Michael Pollak, et al.
Life (Basel, Switzerland)|May 28, 2022
Total Wrist Arthroplasty for Posttraumatic Wrist Osteoarthritis: A Cohort Study Comparing Three IndicationsMatthias Holzbauer, Julian A Mihalic, Michael Pollak, et al.
Cell Metabolism|December 3, 2014
Metformin: from mechanisms of action to therapiesMarc Foretz, Bruno Guigas, Luc Bertrand, et al.
Cancer Letters|July 3, 2007
The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cellsRandy J Levitt, Yunhua Zhao, Marie-José Blouin, et al.
Cancer & Metabolism|September 4, 2014
Metformin directly acts on mitochondria to alter cellular bioenergeticsSylvia Andrzejewski, Simon-Pierre Gravel, Michael Pollak, et al.
Endocrine-Related Cancer|March 16, 2010
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthaseCarolyn Algire, Lilian Amrein, Mahvash Zakikhani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2010
Metformin and the incidence of prostate cancer in patients with type 2 diabetesLaurent Azoulay, Sophie Dell'Aniello, Bruno Gagnon, et al.
Pageof 24

Showing results (41-50 of 236) with videos related to

Sort By:
Pageof 24
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levelsCaroline Diorio, Jacques Brisson, Sylvie Bérubé, et al.
Aging|May 11, 2013
Metformin, aging and cancerOlga Moiseeva, Xavier Deschênes-Simard, Michael Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Vitamin D pathway polymorphisms in relation to mammographic breast densityCaroline Diorio, Marc Sinotte, Jacques Brisson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2016
Exercise and Prostate Cancer: Evidence and Proposed Mechanisms for Disease ModificationBrian D Hayes, Lauren Brady, Michael Pollak, et al.
Life (Basel, Switzerland)|May 28, 2022
Total Wrist Arthroplasty for Posttraumatic Wrist Osteoarthritis: A Cohort Study Comparing Three IndicationsMatthias Holzbauer, Julian A Mihalic, Michael Pollak, et al.
Cell Metabolism|December 3, 2014
Metformin: from mechanisms of action to therapiesMarc Foretz, Bruno Guigas, Luc Bertrand, et al.
Cancer Letters|July 3, 2007
The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cellsRandy J Levitt, Yunhua Zhao, Marie-José Blouin, et al.
Cancer & Metabolism|September 4, 2014
Metformin directly acts on mitochondria to alter cellular bioenergeticsSylvia Andrzejewski, Simon-Pierre Gravel, Michael Pollak, et al.
Endocrine-Related Cancer|March 16, 2010
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthaseCarolyn Algire, Lilian Amrein, Mahvash Zakikhani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2010
Metformin and the incidence of prostate cancer in patients with type 2 diabetesLaurent Azoulay, Sophie Dell'Aniello, Bruno Gagnon, et al.
Pageof 24